CN104306750A - Particle for treating cardiovascular diseases - Google Patents
Particle for treating cardiovascular diseases Download PDFInfo
- Publication number
- CN104306750A CN104306750A CN201410453215.9A CN201410453215A CN104306750A CN 104306750 A CN104306750 A CN 104306750A CN 201410453215 A CN201410453215 A CN 201410453215A CN 104306750 A CN104306750 A CN 104306750A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- heart
- blood vessel
- cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
Abstract
The invention provides a particle for treating cardiovascular diseases. The drug treatment method can help heart disease patients to avoid the heart stent surgery, and is different from the conventional drug treatment methods. In the conventional drug treatment method, the method aims to dissolve the stasis in blood vessel so as to promote the blood circulation. While in the provided treatment method, the drug can recover the heart blood vessels back to the original state so as to eliminate the stasis in heart blood vessels.
Description
Background technology
In current society, the raising of people's living standard, fat and oils and fats, the workload of heart is impelled to increase, some patients, heart does a support and also can't resolve problem, and some patients just do a support after a while, go down like this, must not be permanent plan unexpectedly, the Chinese medicine Opsonizing method of my invention, fundamentally eliminates the misery that heart of patient obstacle brings, the misery making patient exempt support to bring, allows patient normally work.
Summary of the invention
The title of a. inventing exempts from support brother (1) number, this is the product that a kind of cardiac of removing from does stent procedure, theme is the research and development by this product, from the misery truly removing heart of patient disease, the time that effective prolonged human is survived on earth, improve the ability of human survival.B. the technical field belonging to the present invention is a kind of product in therapeutic treatment field.The present invention is the change to human cardiovascular disease's different treatment methods used.C. prior art and background technology.According to present market survey, present hospital is to the Therapeutic Method of cardiovascular diseases, many employings do the method treatment of stent procedure to patient, exempt from the appearance of support brother (1) number, to propose to cure cardiopathic possibility without stent procedure for the mankind, be 99.7% to the effective percentage of the cardiovascular disease such as coronary heart diseases and angina pectoris, myocardial infarction, arrhythmia, heart failure.Write according to " Chinese Chinese medicine information magazine " 10 phases in 2006 " listing of traditional Chinese medical science sage side Purified Guanxin soft capsule " our publication reporter, this is the technical scheme nearest with my investigative technique, simultaneously the described prescription in the inside " dissolve atheromatous plaque prescription; effectively can prevent the deposition again of lipid, thus the continuation of interruption artery atherosclerotic plaque is formed." this Therapeutic Method is unobstructed cardiovascular the inside, and my Therapeutic Method removes the narrow problem of cardiovascular from vascular tissue, makes cardiovascular blood flow unimpeded, to remove patient's slight illness, allows patients ' recovery.D. goal of the invention.The object of the invention is to avoid the deficiency inside only sensible blood vessel and a product making blood vessel itself sensible is provided.If prior art is that inside sensible cardiovascular, if patient is worsened further again, blood vessel itself attenuates further, and the method inside this logical cardiovascular, still exists insufficient therapy.The technical scheme of e. inventing.The object of the invention is to reach by taking the measure of exempting from support brother (1) number.Note: control this disease, patient will put down sleeping, cannot rest one's head on a pillow.Prescription: Herba Polygoni Capitati 6g, Cortex Phellodendri 9g, Herba Oxalidis Corniculatae 13g, Radix Scrophulariae 2g, Radix Rehmanniae 11g, Herba Agrimoniae 13g, Radix Ophiopogonis 15g, Fructus Cannabis 25g, Fructus Aurantii Immaturus 9g, Radix Glycyrrhizae 6g, Rhizoma Imperatae 20g, Radix Et Rhizoma Rhei 8g, Herba Plantaginis 13g, this medicine of Radix Polygoni Multiflori 15g. technique be manufacture method with the general watered pill, instructions of taking, each 6g, every day 1 ~ 2 time.F. the advantage that the present invention compared with prior art has is, this invention can make human treatment cardiovascular diseases more comprehensively, allow the appearance that cardiovascular reply itself is naturally original, blood vessel is allowed to reach the rule of natural aging, thus reach the object of curing cardiovascular diseases, but I does not know that the effect of prior art dissolving atheromatous plaque is much in addition.H. concrete embodiment.The different cardiac of heavy, medium and light is allowed to be the strong explanation to this product to the effect implemented exactly.
Claims (3)
1. this is that a kind of goods allowing cardiovascular be returned to natural aging aspect to cardiac disorder release stent procedure are protected.
2., when according to claims 1, the goods of cardiac disorder release stent procedure is characterized in that heart of patient blood vessel produces obstruction cisco unity malfunction, medicament adjusting used, removes obstacles, and the Therapeutic Method making blood vessel sensible is claimed.
3. prescription described in description: Herba Polygoni Capitati 6g, Cortex Phellodendri 9g, Herba Oxalidis Corniculatae 13g, Radix Scrophulariae 2g, Radix Rehmanniae 11g, Herba Agrimoniae 13g, Radix Ophiopogonis 15g, Fructus Cannabis 25g, Fructus Aurantii Immaturus 9g, Radix Glycyrrhizae 6g, Rhizoma Imperatae 20g, Radix Et Rhizoma Rhei 8g, Herba Plantaginis 13g, Radix Polygoni Multiflori 15g, this prescription kind and dosage claimed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410453215.9A CN104306750A (en) | 2014-09-09 | 2014-09-09 | Particle for treating cardiovascular diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410453215.9A CN104306750A (en) | 2014-09-09 | 2014-09-09 | Particle for treating cardiovascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104306750A true CN104306750A (en) | 2015-01-28 |
Family
ID=52362159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410453215.9A Pending CN104306750A (en) | 2014-09-09 | 2014-09-09 | Particle for treating cardiovascular diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104306750A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1650943A (en) * | 2004-12-03 | 2005-08-10 | 季怀玉 | Medicine for treating high blood pressure disease |
CN102309732A (en) * | 2010-06-30 | 2012-01-11 | 李青 | Traditional Chinese medicine pill for treating arrhythmia |
CN102861225A (en) * | 2012-09-26 | 2013-01-09 | 李承平 | Radix ophiopogonis yin-nourishing and liquid engendering tablets |
CN103721202A (en) * | 2012-10-11 | 2014-04-16 | 王宪凯 | Traditional Chinese medicine pill or treating arrhythmia |
-
2014
- 2014-09-09 CN CN201410453215.9A patent/CN104306750A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1650943A (en) * | 2004-12-03 | 2005-08-10 | 季怀玉 | Medicine for treating high blood pressure disease |
CN102309732A (en) * | 2010-06-30 | 2012-01-11 | 李青 | Traditional Chinese medicine pill for treating arrhythmia |
CN102861225A (en) * | 2012-09-26 | 2013-01-09 | 李承平 | Radix ophiopogonis yin-nourishing and liquid engendering tablets |
CN103721202A (en) * | 2012-10-11 | 2014-04-16 | 王宪凯 | Traditional Chinese medicine pill or treating arrhythmia |
Non-Patent Citations (1)
Title |
---|
冯愉态: "《心血管疾病》", 31 May 2003, 广州出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102078510A (en) | Chinese medicinal composition for treating coronary heart disease | |
CN108704017A (en) | A kind of pharmaceutical composition and its preparation method and application removed necrosis and promoted granulation | |
CN101524521A (en) | Chinese medicinal composition for treating coronary heart disease and preparation method thereof | |
CN102198181B (en) | Antithrombotic and thrombosis-eliminating preparation | |
CN102872337A (en) | External liniment for treating scald | |
CN104306750A (en) | Particle for treating cardiovascular diseases | |
CN104138566A (en) | Medicine for treating angina pectoris heart blood stasis type coronary heart disease | |
CN103479970A (en) | External medicine for treating rheumatic arthralgia | |
CN104138513A (en) | Medicine for treating angina pectoris qi-blood deficiency type coronary heart disease | |
CN102579804B (en) | Chinese medicine for treating stenocardia | |
CN105663370A (en) | Externally-used medicine for treating verruca plantaris | |
CN101617812A (en) | Health-care tea for preventing and treating coronary heart disease | |
CN101537090B (en) | Pharmaceutical composition for treating lumbar intervertebral disc protrusion, preparation method and use thereof | |
CN110694031A (en) | Oral traditional Chinese medicine decoction for invigorating pulse and protecting heart | |
CN104013851A (en) | Traditional Chinese medicine (TCM) preparation for treating beriberi | |
CN107158327A (en) | It is a kind of to treat traditional Chinese medicine for outer use of phlebitis and preparation method thereof | |
CN102670718A (en) | Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method of same | |
CN104288604B (en) | A kind of Chinese medicine composition for treating cerebral infarction | |
CN103566187A (en) | Paste for eliminating sores and promoting tissue regeneration | |
CN103041292B (en) | Traditional Chinese medicine for treating apoplexy | |
CN101396495B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease | |
CN105079687A (en) | Drug combination for treating aneurysm and preparation method and application thereof | |
CN105194105A (en) | Traditional Chinese medicine treating heart blood insufficiency type cardiac arrhythmia | |
CN103239583B (en) | Airuike heart-soothing granule | |
CN103041061B (en) | Stasis-dissolving and pulse-invigorating powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150128 |
|
RJ01 | Rejection of invention patent application after publication |